Zimeng Yang
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 5
- Cancer therapeutics and mechanisms 2
-
- Photodynamic Therapy Research Studies 4
- Co-authors
- Zhonggui He (10 shared papers)Qingzhi Lv (4 shared papers)Wen Li (1 shared paper)Yongjun Wang (6 shared papers)Yu Wang (1 shared paper)Li Yang (1 shared paper)Mo Li (1 shared paper)Qiang Fu (1 shared paper)
- Journals
- Asian Journal of Pharmaceutical Sciences (2 papers)Biomaterials Science (2 papers)Molecular Pharmaceutics (1 paper)Acta Pharmaceutica Sinica B (1 paper)Neoplasia (1 paper)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Zimeng Yang
22 papers receiving 329 citations
Peers
Comparison fields: 5 of 89
- Pharmaceutical Science 60
- Biomaterials 108
- Biomedical Engineering 97
- Catalysis 14
- Energy Engineering and Power Technology 6
Countries citing papers authored by Zimeng Yang
This map shows the geographic impact of Zimeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zimeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zimeng Yang more than expected).
Fields of papers citing papers by Zimeng Yang
This network shows the impact of papers produced by Zimeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zimeng Yang. The network helps show where Zimeng Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zimeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 93 | |
| 2 | 2018 | 36 | |
| 3 | 2020 | 33 | |
| 4 | 2018 | 29 | |
| 5 | 2024 | 28 | |
| 6 | 2018 | 19 | |
| 7 | 2023 | 18 | |
| 8 | 2020 | 18 | |
| 9 | 2020 | 15 | |
| 10 | 2023 | 8 | |
| 11 | 2018 | 7 | |
| 12 | 2021 | 6 | |
| 13 | 2022 | 4 | |
| 14 | 2025 | 3 | |
| 15 | 2022 | 3 | |
| 16 | 2022 | 3 | |
| 17 | 2022 | 3 | |
| 18 | 2023 | 2 | |
| 19 | 2024 | 2 | |
| 20 | 2025 | 1 |
About Zimeng Yang
Zimeng Yang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Biomaterials, Biomedical Engineering and Pharmaceutical Science, having authored 25 papers that have together received 333 indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (6 papers), Nanoplatforms for cancer theranostics (5 papers), RNA Interference and Gene Delivery (5 papers), Photodynamic Therapy Research Studies (4 papers), Advanced Drug Delivery Systems (3 papers), Cancer therapeutics and mechanisms (2 papers), interferon and immune responses (2 papers) and Remote-Sensing Image Classification (2 papers). The work is most often cited by research in Pharmaceutical Science (60 citations), Biomaterials (108 citations), Biomedical Engineering (97 citations), Catalysis (14 citations) and Energy Engineering and Power Technology (6 citations). Zimeng Yang has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Zhonggui He, Qingzhi Lv, Wen Li, Yongjun Wang, Yu Wang, Li Yang, Mo Li, Qiang Fu, Ruoshi Zhang and Jin Sun. Their work appears in journals such as Asian Journal of Pharmaceutical Sciences, Biomaterials Science, Molecular Pharmaceutics, Acta Pharmaceutica Sinica B and Neoplasia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.